• OPEN AN ACCOUNT
Indian Indices
Sensex
74,729.27 413.66
( 0.56%)
Global Indices
Nasdaq
52,191.76 549.28
(1.06%)
Dow Jones
7,764.37 24.43
(0.32%)
Hang Seng
65,489.63 1,063.68
(1.65%)
Nikkei 225
10,840.19 115.33
(1.08%)
Forex
USD-INR
95.08 -0.14
(-0.15%)
EUR-INR
106.23 -0.27
(-0.26%)
GBP-INR
125.74 -0.30
(-0.24%)
JPY-INR
0.60 0.00
(-0.23%)

EQUITY - MARKET SCREENER

3B Blackbio DX Ltd
Industry :  Healthcare
BSE Code
ISIN Demat
Book Value()
532067
INE994E01018
371.7143616
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
3BBLACKBIO
24.59
1252.98
EPS(TTM)
Face Value()
Div & Yield %
59.37
10
0.34
 

Avantel gains after bagging Rs 118-crore order from DRDO
Aug 31,2026
The contract involves the development, installation and commissioning of a ground segment hub for voice and data communication. The project carries a warranty period of 36 months.

The order is scheduled to be executed by February 2029.

Avantel is engaged in the business of designing, developing, and maintaining wireless and satellite communication products, defence electronics, radar systems, and the development of network management software applications for its customers, mainly from the aerospace and defence sectors.

The company reported a 67.39% year-on-year increase in consolidated net profit to Rs 5.39 crore in Q1 FY27, compared with Rs 3.22 crore in Q1 FY26. Revenue from operations rose 35.65% year-on-year to Rs 70.42 crore in Q1 FY27.